Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Newer GLP-1 drugs like semaglutide may cause hair loss.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Elagolix did not effectively treat polycystic ovary syndrome.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

GPR40 agonists help hair growth through the protein ANGPTL4.